SĖKMĖS LABORATORIJA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 258,136 | 298,102 | 219,594 | 252,197 | 296,719 | 293,453 | 294,399 | 292,743 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 118,437 | 120,538 | 122,984 | 156,567 | 115,917 | 105,244 | 84,471 | 63,854 |
| Equity | 257,071 | 177,609 | 145,593 | 208,043 | 178,960 | 124,203 | 109,674 | 73,529 |
| Liabilities | 48,046 | 34,193 | 25,803 | 47,729 | 68,989 | 27,306 | 79,082 | 71,929 |
| Non-current assets | 147,220 | 144,278 | 128,361 | 128,948 | 106,811 | 88,628 | 133,374 | 101,118 |
| Current assets | 157,897 | 67,524 | 43,035 | 126,824 | 141,138 | 62,881 | 55,382 | 44,340 |
| Total assets | 305,117 | 211,802 | 171,396 | 255,772 | 247,949 | 151,509 | 188,756 | 145,458 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 64,782 | 47,766 | 51,525 |
| Social insurance contributions | - | - | - | - | - | 10,166 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -4.6% | +15.5% | -26.3% | +14.8% | +17.7% | -1.1% | +0.3% | -0.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 38.8% | 56.9% | 71.8% | 61.2% | 46.8% | 69.5% | 44.8% | 43.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 46.1% | 67.9% | 84.5% | 75.3% | 64.8% | 84.7% | 77.0% | 86.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 45.9% | 40.4% | 56.0% | 62.1% | 39.1% | 35.9% | 28.7% | 21.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.7 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 64,534 | 73,005 | 54,899 | 73,813 | 74,180 | 88,037 | 98,133 | 97,581 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SĖKMĖS LABORATORIJA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-16 | 2024-04-24 | 72.95 |
SĖKMĖS LABORATORIJA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-02-28 | 2025-03-01 | 0.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SEKMES LABORATORIJA, UAB (code 300151717) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, the company generated revenue of €292.7K and net profit of €63.9K, resulting in a profit margin of 21.8%. Revenue was broadly stable over the last three years, rising slightly from €293.5K in 2023 to €294.4K in 2024 and then edging down to €292.7K in 2025. Net profit followed a weaker trajectory, decreasing from €105.2K in 2023 to €84.5K in 2024 and €63.9K in 2025. The latest year therefore shows a small year-on-year revenue decline of 0.6% and a slight two-year decline of 0.2%. At the end of 2025, total assets stood at €145.5K, equity at €73.5K and liabilities at €71.9K, giving an equity ratio of 50.5% and debt-to-equity of 0.98. Asset turnover was 2.01x, ROE was 86.8% and ROA was 43.9%. Revenue per employee was €97.6K.